Skip to content Skip to footer

Research Portal of the TU Dresden

Dr. Maximilian Hoffmann
Person

Affiliations

Department of Paediatrics
- Academic Staff
- maximilian.hoffmann@tu-dresden.de
Institute of Clinical Pharmacology
- Academic Staff
- maximilian.hoffmann@tu-dresden.de

Identification Numbers

ORCID	0000-0003-3427-8409
Scopus author ID	57217009571

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine

Künzel, S. R., Klapproth, E., Zimmermann, N., Kämmerer, S., Schubert, M., Künzel, K., Hoffmann, M., & 11 othersDrukewitz, S., Vehlow, A., Eitler, J., Arriens, M., Thiel, J., Kronstein-Wiedemann, R., Tietze, M., Beissert, S., Renner, B., El-Armouche, A. & Günther, C., 30 Oct 2024, In: Scientific reports. 14, 1, 26132.

Research output: Contribution to journal › Research article › Contributed › peer-review

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice

Künzel, S. R., Winter, L., Hoffmann, M., Kant, T. A., Thiel, J., Kronstein‐Wiedemann, R., Klapproth, E., & 3 othersLorenz, K., El‐Armouche, A. & Kämmerer, S., Sept 2023, In: Physiological reports. 11, 17, e15809.

Research output: Contribution to journal › Research article › Contributed › peer-review

Untersuchung des therapeutischen Potenzials von Mesalazin bei kardialer und kutaner Fibrose in vitro und in vivo

Hoffmann, M., 2023, 112 p.

Research output: Types of thesis › Doctoral thesis

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation

Künzel, S. R., Hoffmann, M., Weber, S., Künzel, K., Kämmerer, S., Günscht, M., Klapproth, E., & 25 othersRausch, J. S. E., Sadek, M. S., Kolanowski, T., Meyer-Roxlau, S., Piorkowski, C., Tugtekin, S. M., Rose-John, S., Yin, X., Mayr, M., Kuhlmann, J. D., Wimberger, P., Grützmann, K., Herzog, N., Küpper, J-H., O’Reilly, M., Kabir, S. N., Sommerfeld, L. C., Guan, K., Wielockx, B., Fabritz, L., Nattel, S., Ravens, U., Dobrev, D., Wagner, M. & El-Armouche, A., Oct 2021, In: Circulation research. 129, 8, p. 804-820 17 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice

Newe, M., Kant, T. A., Hoffmann, M., Rausch, J. S. E., Winter, L., Künzel, K., Klapproth, E., & 2 othersGünther, C. & Künzel, S. R., Aug 2021, In: Naunyn-Schmiedeberg's archives of pharmacology. 394, 11, p. 2233-2244 12 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Research Portal of the TU Dresden

Dr. Maximilian Hoffmann
Person

Affiliations

Identification Numbers

Related content

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice

Untersuchung des therapeutischen Potenzials von Mesalazin bei kardialer und kutaner Fibrose in vitro und in vivo

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice

Erich-Glowatzky-Preis